Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky Sells 187,655 Shares

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) CEO Eric P. Lefkofsky sold 187,655 shares of the stock in a transaction on Wednesday, December 18th. The shares were sold at an average price of $37.54, for a total value of $7,044,568.70. Following the sale, the chief executive officer now directly owns 9,557,283 shares in the company, valued at $358,780,403.82. This trade represents a 1.93 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Tempus AI Stock Performance

TEM traded up $2.51 during trading on Friday, reaching $35.54. 5,785,145 shares of the company's stock were exchanged, compared to its average volume of 1,582,344. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. Tempus AI, Inc. has a 1 year low of $22.89 and a 1 year high of $79.49. The stock has a fifty day moving average of $51.70.

Institutional Trading of Tempus AI

A number of hedge funds and other institutional investors have recently made changes to their positions in TEM. Kovitz Investment Group Partners LLC acquired a new position in Tempus AI in the third quarter valued at approximately $1,367,000. Sumitomo Mitsui Trust Group Inc. increased its holdings in shares of Tempus AI by 1,591.2% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company's stock valued at $68,922,000 after purchasing an additional 1,145,698 shares in the last quarter. Captrust Financial Advisors acquired a new position in shares of Tempus AI in the 3rd quarter valued at $2,726,000. Sigma Planning Corp purchased a new stake in Tempus AI during the third quarter worth $1,323,000. Finally, Dakota Wealth Management acquired a new stake in Tempus AI during the third quarter valued at $1,185,000. Institutional investors and hedge funds own 24.22% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on TEM. Wolfe Research initiated coverage on shares of Tempus AI in a report on Friday, December 13th. They issued an "outperform" rating and a $60.00 price target on the stock. Loop Capital boosted their target price on Tempus AI from $48.00 to $57.00 and gave the stock a "buy" rating in a research note on Tuesday, October 15th. Stifel Nicolaus cut Tempus AI from a "buy" rating to a "hold" rating and increased their price target for the company from $45.00 to $65.00 in a research note on Monday, November 11th. Bank of America boosted their price target on Tempus AI from $52.00 to $54.00 and gave the stock a "neutral" rating in a research note on Friday, December 13th. Finally, Piper Sandler reaffirmed a "neutral" rating and issued a $70.00 price objective (up from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $56.00.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.